source
- Lilly presents early data supporting GLP-1/GIP candidate's potential in depression, alcohol use disorderWith a trillion-dollar market cap and a wildly successful GLP-1 portfolio, Eli Lilly isn’t resting on its laurels. At the Psych Congress 2026, the company presented early-stage data that could supp…
- Insurers Begin Accelerating AI Adoption After Lagging Behind ProvidersInsurers have traditionally been slower than health-care providers in adopting artificial intelligence tools, but the gap is narrowing. A growing share of insurers now say they plan to significant…